Yulong He

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2021 · 440 citations

Medicine, Oncology, Surgery +17

Gender Differences in Gastric Cancer Survival: 99,922 Cases Based on the SEER Database

Huafu Li, Zhewei Wei, Chunming Wang et al. · Journal of Gastrointestinal Surgery · 2019 · 80 citations

Medicine, Oncology, Surgery +14

ZEB2 promotes tumor metastasis and correlates with poor prognosis of human colorectal cancer.

Mingzhe Li, Jingjing Wang, Shibin Yang et al. · PubMed · 2017 · 56 citations

Medicine, Cell Biology, Oncology +17

Spleen Preservation in Radical Surgery for Gastric Cardia Cancer

Changhua Zhang, Wen-hua Zhan, Yulong He et al. · Annals of Surgical Oncology · 2007 · 52 citations

Medicine, Oncology, Surgery +16

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trial

Xiaotian Zhang, Liang Han, Ziyu Li et al. · The Lancet Oncology · 2025 · 49 citations

Medicine, Oncology, Surgery +16